was originally recognized in Drosophila as a group of "neurogenic" loci, and loss of its function was followed by formation of excessive neural cells at the expense of epithelial cells. 7 The three MAML genes are extensively expressed in adult tissues. The MAML proteins amend Notch signaling in various cell types based on their expression levels and activities and thus contribute to the diversity of the biological effects rising from Notch activation. 6 In vivo, single MAML coactivator contributes to the molecular specificity of Notch receptor functions. 5 MAML1, a human homologue of Drosophila Mastermind, has a cytogenetic location at 5q35.3. 6 It is known to play a role in myogenesis, coactivates p53 required for p53-mediated germ-cell apoptotic response, and β-catenin-based transcriptional events. 5 Yoshida et al 8 have studied the pathological significance of Notch1 and its activation mechanism in the pathogenesis of oral squamous cell carcinoma (OSCC) and found increased expression of Notch1 and NICD with their localization at the invasive tumor front. Moreover, they emphasized the role of MAML family of coactivators in the development and progression of OSCC. Sun et al 9 have also carried out an extensive study to reveal that four genes, including MAML3, were found to be downregulated in head and neck cancer.
Luk et al 10 studied diagnostic and prognostic utility of MAML2 gene rearrangement detection by fluorescent in situ hybridization in mucoepidermoid carcinoma of the salivary glands and concluded that MAML2 rearrangement is not unusual and unambiguous for mucoepidermoid carcinoma, which highlights its diagnostic implication. Moreover, it has been hinted that MAML2 rearrangement predicts a favorable prognosis.
Most of the analyses have researched MAML1, but it has been determined that both MAML2 and MAML3 interact with the Notch receptors. 11 There are binding proteins specific for each MAML contributing to their differential activation and activities. The constant association of oral cancer with innumerable disorders (oral potentially malignant disorders and cancer inherited syndromes 12 ) along with new discoveries in its pathogenesis and biology 13 makes it a potential area to study MAML genes. Thus, futher work is required to scrutinize the fundamental purviews of the MAML family and their precise interacting allies. These coactivators can prove to be excellent candidates in evolving the therapeutic regime for various oral malignancies. Exploring MAML functions in other signaling pathways like Wnt and p53 can prove to be of therapeutic significance. 5 In conclusion, comprehensive expression outlines of the three MAMLs in various tissues and at diverse development phases can help to manipulate and deliver a specific target therapy in oral malignancies.
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